Sunshine transparency reporting for emerging pharma: Simplify, streamline, and secure

Pharmaceutical and medical device manufacturers launching their first product in the US face several complex challenges while preparing for the required collection and reporting of transfers of value provided to healthcare providers (HCPs) and healthcare organisations (HCOs). The many unique federal and state legal requirements, coupled with steep penalties for inaccurate, incomplete, or late reporting, underscore the critical need for a strategic, well-organised transparency reporting programme.

You can read the full article on to learn more.

We’re here to support your success from clinical to commercial – and beyond.

How can we help you today?